Roy First

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Physiology

Chemicals & Drugs

Concepts & Ideas

Living Beings

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Miao Yun; Everly Jason J; Gross Thomas G; Tevar Amit D; First M Roy; Alloway Rita R; Woodle E Steve
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
Walker Jennifer K; Alloway Rita R; Roy-Chaudhury Prabir; Mogilishetty Gautham; Cardi Michael A; Weimert Nicole A; Rike Adele H; First M Roy; Woodle E Steve
A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
Woodle E Steve; First M Roy; Pirsch John; Shihab Fuad; Gaber A Osama; Van Veldhuisen Paul;
A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Roy First (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Miao Yun; Everly Jason J; Gross Thomas G; Tevar Amit D; First M Roy; Alloway Rita R; Woodle E Steve
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
Transplantation 2009;87(9):1347-59.
2009: Walker Jennifer K; Alloway Rita R; Roy-Chaudhury Prabir; Mogilishetty Gautham; Cardi Michael A; Weimert Nicole A; Rike Adele H; First M Roy; Woodle E Steve
A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
Transplantation 2009;87(3):408-14.
2008: Woodle E Steve; First M Roy; Pirsch John; Shihab Fuad; Gaber A Osama; Van Veldhuisen Paul;
A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
Annals of surgery 2008;248(4):564-77.
2008: Bolin Paul; Shihab Fuad S; Mulloy Laura; Henning Alice K; Gao Jeff; Bartucci Marilyn; Holman John; First M Roy;
Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Transplantation 2008;86(1):88-95.
2008: Shihab Fuad S; Waid Thomas H; Conti David J; Yang Harold; Holman Michael J; Mulloy Laura C; Henning Alice K; Holman John; First M Roy;
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study.
Transplantation 2008;85(9):1261-9.
2008: First M Roy
First clinical experience with the new once-daily formulation of tacrolimus.
Therapeutic drug monitoring 2008;30(2):159-66.
2007: Alloway Rita; Steinberg Steven; Khalil Kassem; Gourishankar Sita; Miller Joshua; Norman Douglas; Hariharan Sundaram; Pirsch John; Matas Arthur; Zaltzman Jeffrey; Wisemandle Kathleen; Fitzsimmons William; First M Roy
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
Transplantation 2007;83(12):1648-51.
2007: Florman Sander; Alloway Rita; Kalayoglu Munci; Punch Jeffrey; Bak Thomas; Melancon Joseph; Klintmalm Goran; Busque Stephan; Charlton Michael; Lake John; Dhadda Shobha; Wisemandle Kathleen; Wirth Mary; Fitzsimmons William; Holman John; First M Roy
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
Transplantation 2007;83(12):1639-42.
2007: Heffron T G; Pescovitz M D; Florman S; Kalayoglu M; Emre S; Smallwood G; Wisemandle K; Anania C; Dhadda S; Sawamoto T; Keirns J; Fitzsimmons W; First M R
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(6):1609-15.
2007: Silva H T; Yang H C; Abouljoud M; Kuo P C; Wisemandle K; Bhattacharya P; Dhadda S; Holman J; Fitzsimmons W; First M Roy
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(3):595-608.
2007: Woodle E Steve; Alloway Rita; Rike Adele; Roy-Chaudhury Prabir; Tevar Amit; Susskind Brian; Everly Jason; Mogilishetty Gautham; Brailey Paul; Govil Amit; Rudich Steve; First M Roy; Alexander J Wesley; Munda Rino; Cardi Michael; Arend Lois
Corticosteroid elimination: the Cincinnati experience.
Clinical transplants 2007;():51-60.
2006: Luxon Alesha; First M Roy
Diabetes: one part of the cardiovascular problem post-transplant.
Nephrology news & issues 2006;20(10):33-4.
2005: Woodle E Steve; Alloway Rita R; Buell Joseph F; Alexander J Wesley; Munda Rino; Roy-Chaudhury Prabir; First M Roy; Cardi Michael; Trofe Jennifer
Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(11):2740-4.
2005: Rogers Christin C; Alloway Rita R; Buell Joseph F; Boardman Robyn; Alexander J Wesley; Cardi Michael; Roy-Chaudhury Prabir; First M Roy; Succop Paul; Munda Rino; Woodle E Steve
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression.
Transplantation 2005;80(1):26-33.
2005: Trofe Jennifer; Buell Joseph F; Beebe Thomas M; Hanaway Michael J; First M Roy; Alloway Rita R; Gross Thomas G; Succop P; Woodle E Steve
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(4 Pt 1):775-80.
2005: Florman S; Alloway R; Kalayoglu M; Lake K; Bak T; Klein A; Klintmalm G; Busque S; Brandenhagen D; Lake J; Wisemandle K; Fitzsimmons W; First M R
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
Transplantation proceedings 2005;37(2):1211-3.
2005: Woodle E S; Gupta M; Buell J F; Neff G W; Gross T G; First M R; Hanaway M J; Trofe J
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience.
Transplantation proceedings 2005;37(2):958-9.
2005: Buell J F; Gross T G; Hanaway M J; Trofe J; Muthiak C; First M R; Alloway R R; Woodle E S
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience.
Transplantation proceedings 2005;37(2):956-7.
2005: Buell J F; Gross T G; Hanaway M J; Trofe J; Roy-Chaudhury P; First M R; Woodle E S
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.
Transplantation proceedings 2005;37(2):954-5.
2005: Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First M R
Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Transplantation proceedings 2005;37(2):867-70.
2005: Boardman R E; Alloway R R; Alexander J W; Buell J F; Cardi M; First M R; Hanaway M T; Munda R; Rogers C C; Roy-Chaudhury P; Susskind B; Trofe J; Woodle E S
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
Transplantation proceedings 2005;37(2):814-6.
2005: Buell J F; Hanaway M J; Thomas M; Munda R; Alloway R R; First M R; Woodle E S
Donor kidneys with small renal cell cancers: can they be transplanted?
Transplantation proceedings 2005;37(2):581-2.
2005: Buell Joseph F; Beebe Thomas M; Gross Thomas G; Trofe Jennifer; Hanaway Michael J; Alloway Rita R; First M Roy; Woodle E Steve
United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data.
Transplantation 2005;79(5):623.
2005: Alexander J Wesley; Metze Timothy J; McIntosh Matthew J; Goodman Hope R; First M Roy; Munda Rino; Cardi Michael A; Austin Joe N; Goel Sharad; Safdar Shahzad; Greenberg Norman; Chen Xiaowu; Woodle E Steve
The influence of immunomodulatory diets on transplant success and complications.
Transplantation 2005;79(4):460-5.
2005: Buell Joseph F; Lee Lucy; Martin Jill E; Dake Natalie A; Cavanaugh Teresa M; Hanaway Michael J; Weiskittel Pat; Munda Rino; Alexander J Wesley; Cardi Michael; Peddi V Ram; Zavala Edward Y; Berilla Elaine; Clippard Marketa; First M Roy; Woodle E Steve
Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study.
Clinical transplantation 2005;19(1):102-9.
2005: Boardman Robyn E; Alloway Rita R; Alexander J Wesley; Buell Joseph F; Cardi Michael; First M Roy; Hanaway Michael J; Munda Rino; Rogers Christin C; Roy-Chaudhury Prabir; Susskind Brian; Trofe Jennifer; Woodle E Steve
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(2):356-65.
2004: Fitzsimmons William E; First M Roy
FK778, a synthetic malononitrilamide.
Yonsei medical journal 2004;45(6):1132-5.
2004: First M Roy; Fitzsimmons William E
Modified release tacrolimus.
Yonsei medical journal 2004;45(6):1127-31.
2004: Aull Meredith J; Buell Joseph F; Trofe Jennifer; First M Roy; Alloway Rita R; Hanaway Michael J; Wagoner Lynne; Gross Thomas G; Beebe Thomas; Woodle E Steve
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.
Transplantation 2004;78(11):1676-82.
2004: First M Roy
Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19 Suppl 6():vi17-vi22.
2004: First M Roy
Tacrolimus based immunosuppression.
Journal of nephrology 2004;17 Suppl 8():S25-31.
2004: Trofe Jennifer; Buell Joseph F; Woodle E Steve; Beebe Thomas M; Hanaway Michael J; First M Roy; Alloway Rita R; Gross Thomas G
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma.
Transplantation 2004;78(7):972-7.
2004: Trofe Jennifer; Beebe Thomas M; Buell Joseph F; Hanaway Michael J; First M Roy; Alloway Rita R; Gross Thomas G; Woodle E Steve
Posttransplant malignancy.
Progress in transplantation (Aliso Viejo, Calif.) 2004;14(3):193-200.
2004: Peters Thomas G; Spinola Kristin N; West John C; Aeder Mark I; Danovitch Gabriel M; Klintmalm Goran B G; Gorman Kevin J; Gordon John A; Kincaid Carl H; First M Roy
Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects.
Transplantation 2004;78(4):537-43.
2004: First M Roy; Fitzsimmons William E
New drugs to improve transplant outcomes.
Transplantation 2004;77(9 Suppl):S88-92.
2004: First M Roy
New-onset diabetes after transplantation.
Transplantation 2004;77(7):1128-9;author reply 1129-30.
2003: Buell Joseph F; Trofe Jennifer; Sethuraman Gopalan; Hanaway Michael J; Beebe Thomas M; Gross Thomas G; Alloway Rita; First M Roy; Woodle E Steve
Donors with central nervous system malignancies: are they truly safe?
Transplantation 2003;76(2):340-3.
2003: First M Roy
Posttransplant diabetes mellitus.
Transplantation 2003;75(10):1769.
2003: First M Roy
Renal function as a predictor of long-term graft survival in renal transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 1():i3-6.
2003: Aull Meredith J; Buell Joseph F; Peddi V R; Trofe Jennifer; Beebe Thomas M; Hanaway Michael J; Roy-Chaudhury Prabir; Alloway Rita R; First M Roy; Woodle E Steve;
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature.
Transplantation 2003;75(2):225-8.
2003: Witherow Beth Ann; Roth Gregory S; Carrozza Mark A; Freyberg Ronald W; Kopke Jonathan E; Alloway Rita R; Buell Joseph F; First M Roy; Gross Thomas G; Hanaway Michael J; Trofe Jennifer; Woodle E Steve; Beebe Thomas M
The Israel Penn International Transplant Tumor Registry.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2003;():1053.
2002: Buell Joseph F; Husted Thomas; Hanaway Michael J; Peddi V Ram; Trofe Jennifer; Gross Thomas G; Beebe Thomas M; First M Roy; Woodle E Steve
Incidental diagnosis of gastric cancer in transplant recipients improves patient survival.
Surgery 2002;132(4):754-8; discussion 758-60.
2002: Alexander J W; Stanley L L; Ofstedal T L; First M R; Cardi M A; Safdar S; Mendoza N C; Munda R; Fidler J P; Buell J F; Hanaway M J; Woodle E S
Transplantation without steroids.
Transplantation proceedings 2002;34(6):2076-8.
2002: Trofe Jennifer; Cavallo T; First M R; Weiskittel P; Peddi V R; Roy-Chaudhury P; Alloway R R; Safdar S; Buell J F; Hanaway M J; Woodle E S
Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring.
Transplantation proceedings 2002;34(5):1788-9.
2002: Husted T L; Buell J F; Hanaway M J; Trofe J; Beebe T; Gross T; First M R; Woodle E S
De novo sarcomas in solid organ transplant recipients.
Transplantation proceedings 2002;34(5):1786-7.
2002: Buell Joseph F; Husted T; Hanaway M J; Trofe J; Gross T; Beebe T; First M R; Woodle E S
Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy.
Transplantation proceedings 2002;34(5):1784-5.
2002: Buell Joseph F; Trofe J; Hanaway M J; Beebe T M; Gross T G; Alloway R R; First M R; Woodle E S
Immunosuppression and Merkel cell cancer.
Transplantation proceedings 2002;34(5):1780-1.
2002: Buell Joseph F; Hanaway M J; Trofe J; Gross T G; Beebe T M; Alloway R R; First M R; Woodle E S
De novo breast cancer in renal transplant recipients.
Transplantation proceedings 2002;34(5):1778-9.
2002: First M Roy
Immunosuppressive [correction of immunosupressive] agents and their actions.
Transplantation proceedings 2002;34(5):1369-71.
2002: Peddi V Ram; Bryant Margaret; Roy-Chaudhury Prabir; Woodle E Steve; First M Roy
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.
Transplantation 2002;73(9):1514-8.
2002: First M Roy; Gerber David A; Hariharan Sundaram; Kaufman Dixon B; Shapiro Ron
Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management.
Transplantation 2002;73(3):379-86.
2002: Trofe Jennifer; Buell Joseph F; First M Roy; Hanaway Michael J; Beebe Tom M; Woodle E Steve
The role of immunosuppression in lymphoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2002;159():55-66.
2001: First M R; Peddi V R; Weiskittel P; Woodle E S
Control of risk factors for cardiovascular disease in long-term renal transplant recipients.
Transplantation proceedings 2001;33(7-8):3674-5.
2001: Woodle E S; Hanaway M; Buell J; Gross T; First M R; Trofe J; Beebe T;
Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry.
Transplantation proceedings 2001;33(7-8):3660-1.
2001: Woodle E S; Buell J; Hanaway M; First M R; Trofe J;
Biologic behavior of carcinoid tumors in solid organ transplant recipients: the Israel Penn international transplant tumor registry experience.
Transplantation proceedings 2001;33(7-8):3656-7.
2001: Peddi V R; Weiskittel P; Alexander J W; Woodle E S; First M R
HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival.
Transplantation proceedings 2001;33(7-8):3411-3.
2001: Buell J F; Trofe J; Hanaway M J; Lo A; Rosengard B; Rilo H; Alloway R; Beebe T; First M R; Woodle E S
Transmission of donor cancer into cardiothoracic transplant recipients.
Surgery 2001;130(4):660-6; discussion 666-8.
2001: First M R
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population.
Transplantation 2001;72(6 Suppl):S20-4.
2001: Kelly B S; Alexander J W; Dreyer D; Greenberg N A; Erickson A; Whiting J F; Ogle C K; Babcock G F; First M R
Oral arginine improves blood pressure in renal transplant and hemodialysis patients.
JPEN. Journal of parenteral and enteral nutrition 2001;25(4):194-202.
2001: First M R
Case 2: Post-transplant diabetes mellitus in renal transplantation.
Transplantation 2001;71(12):1872-3.
2001: First M R
Case 1: persistent acute rejection after kidney transplantation.
Transplantation 2001;71(11):1697-8.
2001: Peddi V R; First M R
Recent advances in immunosuppressive therapy for renal transplantation.
Seminars in dialysis 2001;14(3):218-22.
2001: First M R
Tailoring immunosuppressive therapy based on donor and recipient risk factors.
Transplantation proceedings 2001;33(3):2207-11.
2001: Phillips A L; Walker E L; Martin J E; First M R; Hanto D W; Whiting J F
Quality of life as a predictor of morbidity, mortality, and resource utilization after solid organ transplant.
Transplantation proceedings 2001;33(1-2):1922.
2001: Martin J E; Shireman T I; First M R; Whiting J F
Quality of life following solid organ transplantation in Medicaid beneficiaries.
Transplantation proceedings 2001;33(1-2):1909.
2001: Boyd S R; Martin J E; First M R; Whiting J F
Health utility scores following renal transplantation.
Transplantation proceedings 2001;33(1-2):1900.
2001: Phillips A L; Walker E L; Martin J E; First M R; Hanto D W; Whiting J F
Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant.
Transplantation proceedings 2001;33(1-2):1886.
2001: First M R
The organ shortage and allocation issues.
Transplantation proceedings 2001;33(1-2):806-10.
2001: Chaudhury P R; Alexander J W; First M R; Peddi V R; Munda R M; Cavallo T
Immediate allograft dysfunction due to atheroembolic disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;37(2):423-6.
2000: Brown M R; Noffsinger A; First M R; Penn I; Husseinzadeh N
HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients.
Gynecologic oncology 2000;79(2):220-4.
2000: Whiting J F; Woodward R S; Zavala E Y; Cohen D S; Martin J E; Singer G G; Lowell J A; First M R; Brennan D C; Schnitzler M A
Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments.
Transplantation 2000;70(5):755-60.
2000: First M R
Hepatitis C virus infection in the renal transplant recipient.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15 Suppl 8():60-4.
1999: Penn I; First M R
Merkel's cell carcinoma in organ recipients: report of 41 cases.
Transplantation 1999;68(11):1717-21.
1999: Alexander J W; Light J A; Donaldson L A; Delmonico F L; Diethelm A G; Wilkinson A; Rosenthal J T; Thistlethwaite J R; Hunsicker L G; Matas A J; First M R; Reinsmoen N L; Rose S M
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.
Transplantation 1999;68(8):1117-24.
1999: Dean D E; Kamath S; Peddi V R; Schroeder T J; First M R; Cavallo T
A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management.
Transplantation 1999;68(5):642-5.
1999: Canafax D M; Irish W D; Moran H B; Squiers E; Levy R; Pouletty P; First M R; Christians U
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and Neoral.
Pharmacology 1999;59(2):78-88.
1999: Shah M B; Martin J E; Schroeder T J; First M R
The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis.
Transplantation 1999;67(11):1411-7.
1999: Schroeder T J; Moore L W; Gaber L W; Gaber A O; First M R
The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design.
Transplantation proceedings 1999;31(3B Suppl):1S-6S.
1999: Martin J E; Daoud A J; Schroeder T J; First M R
The clinical and economic potential of cyclosporin drug interactions.
PharmacoEconomics 1999;15(4):317-37.
1999: Whiting J F; Zavala E Y; Alexander J W; First M R
The cost-effectiveness of transplantation with expanded donor kidneys.
Transplantation proceedings 1999;31(1-2):1320-1.
1999: Peddi V R; Schroeder T J; Weiskittel P; First M R
Graft outcome in patients with biopsy-proven chronic renal allograft rejection.
Transplantation proceedings 1999;31(1-2):1308-9.
1999: Peddi V R; Munda R; Demmy A M; First M R
Long-term outcome in simultaneous kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation.
Transplantation proceedings 1999;31(1-2):608-9.
1999: Gaston R; Alloway R R; Gaber A O; Rossi S J; Schroeder T J; Irish W D; Canafax D M; First M R
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.
Transplantation proceedings 1999;31(1-2):326-7.
1999: First M R; Weiskittel P; Burton M L; Shah M B; Dreyer D; Fleck P; Bey C; Peddi V R; Canafax D M; Schroeder T J
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune.
Transplantation proceedings 1999;31(1-2):324-5.
1999: Khosla U M; Martin J E; Baker G M; Schroeder T J; First M R
One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation.
Transplantation proceedings 1999;31(1-2):274-5.
1999: Golconda M S; Valente J F; Bejarano P; Gilinsky N; First M R
Mycophenolate mofetil-induced colonic ulceration in renal transplant recipients.
Transplantation proceedings 1999;31(1-2):272-3.
1999: First M R
Immunologically high-risk recipient strategies.
Transplantation proceedings 1999;31(1-2):243-6.
1999: Shah M B; Martin J E; Schroeder T J; First M R
Validity of open labeled versus blinded trials: a meta-analysis comparing Neoral and Sandimmune.
Transplantation proceedings 1999;31(1-2):217-9.
1998: Baker G M; Martin J E; Jang R; Schroeder T J; Armitstead J A; Myre S; First M R
Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Transplantation proceedings 1998;30(8):4082-4.
1998: Daoud A J; Schroeder T J; Shah M; Hariharan S; Peddi V R; Weiskittel P; First M R
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus.
Transplantation proceedings 1998;30(8):4079-81.
1998: Fleck P R; Schroeder T J; Dauod A J; Peddi V R; First M R
Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine.
Transplantation proceedings 1998;30(8):4070-2.
1998: Shah M B; Martin J E; Schroeder T J; First M R
A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
Transplantation proceedings 1998;30(8):4048-53.
1998: First M R; Weiskittel P; Shah M; Peddi V R; Canafax D; Schroeder T J
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
Transplantation proceedings 1998;30(8):3955-7.
1998: First M R; Alloway R; Schroeder T J
Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral.
Clinical transplantation 1998;12(6):518-24.
1998: Peddi V R; Kamath S; Munda R; Demmy A M; Alexander J W; First M R
Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
Clinical transplantation 1998;12(5):401-5.
1998: First M R; Peddi V R
Malignancies complicating organ transplantation.
Transplantation proceedings 1998;30(6):2768-70.
1998: First M R; Weiskittel P; Burton M; Shah M; Dreyer D; Fleck P; Bey C; Peddi R; Canafax D; Schroeder T J
Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method.
Transplantation proceedings 1998;30(5):1701-5.
1998: Shah M B; Martin J E; Schroeder T J; First M R
Evaluation of the safety and tolerability of Neoral and Sandimmune: a meta-analysis.
Transplantation proceedings 1998;30(5):1697-700.
1998: Kaplan A J; Valente J F; First M R; Demmy A M; Munda R
Early operative intervention for urologic complications of kidney-pancreas transplantation.
World journal of surgery 1998;22(8):890-4.
1998: Gaber A O; First M R; Tesi R J; Gaston R S; Mendez R; Mulloy L L; Light J A; Gaber L W; Squiers E; Taylor R J; Neylan J F; Steiner R W; Knechtle S; Norman D J; Shihab F; Basadonna G; Brennan D C; Hodge E E; Kahan B D; Kahan L; Steinberg S; Woodle E S; Chan L; Ham J M; Schroeder T J
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
Transplantation 1998;66(1):29-37.
1998: Peddi V R; Whiting J; Weiskittel P D; Alexander J W; First M R
Characteristics of long-term renal transplant survivors.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(1):101-6.
1998: Peddi V R; Munda R; Demmy A M; Alexander J W; First M R
Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation.
Transplantation proceedings 1998;30(4):1541-3.
1998: Kamath S; Dean D; Peddi V R; Schroeder T J; Alexander J W; Cavallo T; First M R
Primary therapy with OKT3 for biopsy-proven acute renal allograft rejection.
Transplantation proceedings 1998;30(4):1178-80.
1998: Guttmann R D; Soulillou J P; Moore L W; First M R; Gaber A O; Pouletty P; Schroeder T J
Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6 Suppl 1):S40-6.
1998: Al-Awwa I A; Hariharan S; First M R
Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6 Suppl 1):S15-8.
1998: Peddi V R; Demmy A M; Munda R; Alexander J W; First M R
Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
Transplantation proceedings 1998;30(2):509-11.
1998: Peddi V R; Kamath S; Schroeder T J; Munda R; First M R
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
Transplantation proceedings 1998;30(2):285-7.
1998: First M R
Clinical application of immunosuppressive agents in renal transplantation.
The Surgical clinics of North America 1998;78(1):61-76.
1998: Gaber L W; Moore L W; Gaber A O; First M R; Guttmann R D; Pouletty P; Schroeder T J; Soulillou J P
Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.
Transplantation 1998;65(3):376-80.
1998: Whiting J F; Golconda M; Smith R; O'Brien S; First M R; Alexander J W
Economic costs of expanded criteria donors in renal transplantation.
Transplantation 1998;65(2):204-7.
1997: Golconda M S; Whiting J F; Smith R; Hayes R; Alexander J W; First M R
Long-term outcome of kidney transplantation from expanded criteria donors: a single center experience.
Transplantation proceedings 1997;29(8):3379-81.
1997: First M R
The donor supply.
Transplantation proceedings 1997;29(8):3299-3300.
1997: Whiting J F; Golconda M; Smith R; O'Brien S; First M R; Alexander J W
Clinical and economic outcomes of expanded criteria donors in renal transplantation.
Transplantation proceedings 1997;29(8):3258.
1997: Kamath S; Dean D; Peddi V R; Schroeder T J; Alexander J W; Cavallo T; First M R
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection.
Transplantation 1997;64(10):1428-32.
1997: Daoud A J; Schroeder T J; Kano J; Horn H R; Moran H B; First M R
The US compassionate experience with thymoglobulin for the treatment of resistant acute rejection.
Transplantation proceedings 1997;29(7A):18S-20S.
1997: Rahusen F; Munda R; Hariharan S; First M R; Demmy A
Combined kidney-pancreas and parathyroid transplantation: a case report.
Clinical transplantation 1997;11(4):341-3.
1997: Valente J F; Hariharan S; Peddi V R; Schroeder T J; Ogle C K; Alexander J W; First M R
Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era.
Clinical transplantation 1997;11(3):231-6.
1997: First M R
Xenotransplantation: social, ethical, religious, and political issues.
Kidney international. Supplement 1997;58():S46-7.
1997: Hariharan S; Peddi V R; Munda R; Demmy A M; Schroeder T J; Alexander J W; First M R
Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation.
Transplantation proceedings 1997;29(1-2):652-3.
1997: el-Ghoroury M; Hariharan S; Peddi V R; Munda R; Schroeder T J; Demmy A M; Alexander J W; First M R
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients.
Transplantation proceedings 1997;29(1-2):649-51.
1997: Schroeder T J; Levy R; Pouletty P; First M R
A generic cyclosporine development program.
Transplantation proceedings 1997;29(1-2):1235-8.
1997: First M R
Cadaveric organ procurement--an overview of two aspects: donor hospital networks, and minority donation.
Transplantation proceedings 1997;29(1-2):70-2.
1997: First M R
Controversies in organ donation: minority donation and living unrelated renal donors.
Transplantation proceedings 1997;29(1-2):67-9.
1997: Gaber L W; Moore L W; Gaber A O; First M R; Guttmann R D; Pouletty P; Schroeder T J; Soulillou J P
A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints Conference.
Transplantation proceedings 1997;29(1-2):184-5.
1997: Peddi V R; Dean D E; Hariharan S; Cavallo T; Schroeder T J; First M R
Proteinuria following renal transplantation: correlation with histopathology and outcome.
Transplantation proceedings 1997;29(1-2):101-3.
1997: First M R
An update on new immunosuppressive drugs undergoing preclinical and clinical trials: potential applications in organ transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(2):303-17.
1997: Ram Peddi V; Hariharan S; Schroeder T J; First M R
Impact of ganciclovir prophylaxis on cytomegalovirus infection in recipients of cadaveric renal allografts.
Nephron 1997;76(1):49-55.
1996: Marterre W F; Hariharan S; First M R; Alexander J W
Gastric bypass in morbidly obese kidney transplant recipients.
Clinical transplantation 1996;10(5):414-9.
1996: Hariharan S; Smith R D; Viero R; First M R
Diabetic nephropathy after renal transplantation. Clinical and pathologic features.
Transplantation 1996;62(5):632-5.
1996: Cavallo T; First M R
"Recurrence" of cyclosporine nephropathy in a heart transplant recipient.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(3):466-8.
1996: Skannal D G; Miodovnik M; Dungy-Poythress L J; First M R
Successful pregnancy after combined renal-pancreas transplantation: a case report and literature review.
American journal of perinatology 1996;13(6):383-7.
1996: Schroeder T J; Shah M; Hariharan S; First M R
Increased resources are required in patients with low cyclosporine bioavailability.
Transplantation proceedings 1996;28(4):2151-5.
1996: Hariharan S; Alexander J W; Schroeder T J; First M R
Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Clinical transplantation 1996;10(2):186-90.
1996: Peddi V R; Hariharan S; First M R
Disseminated histoplasmosis in renal allograft recipients.
Clinical transplantation 1996;10(2):160-5.
1996: Hariharan S; Munda R; Cavallo T; Demmy A M; Schroeder T J; Alexander J W; First M R
Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity.
Transplantation 1996;61(8):1161-5.
1996: First M R; Schroeder T J; Monaco A P; Simpson M A; Curtis J J; Armenti V T
Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations.
Clinical transplantation 1996;10(1 Pt 1):55-9.
1996: Rossi S; Schroeder T; Muth K; Hanto D; Munda R; Hariharan S; First M R; Ryckman F; Balistreri W
Serial monitoring of soluble interleukin-2 receptor as a rapid marker of cytomegalovirus infection and response to antiviral therapy.
Clinical transplantation 1996;10(1 Pt 1):45-50.
1996: Peddi V R; Hariharan S; Schroeder T J; First M R
Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients.
Clinical transplantation 1996;10(1 Pt 1):20-3.
1996: Viero R M; First M R; Cavallo T
Detection of Epstein-Barr virus message in renal allografts.
Transplantation 1996;61(2):321-3.
1995: el-Ghoroury M; Hariharan S; Munda R; Demmy A M; Schroeder T J; Alexander J W; First M R
Comparison between methylprednisolone and OKT3 treatment for the first acute rejection episode in combined kidney and pancreas transplant recipients.
Transplantation proceedings 1995;27(6):3133-4.
1995: Peddi V R; Hariharan S; Munda R; Schroeder T J; First M R
Impact of ganciclovir prophylaxis on cytomegalovirus infection in cadaveric kidney vs combined kidney and pancreas transplantation.
Transplantation proceedings 1995;27(6):3076-7.
1995: Hariharan S; Munda R; Demmy A M; Schroeder T J; Alexander J W; First M R
Conversion from cyclosporine to tacrolimus after pancreas transplantation.
Transplantation proceedings 1995;27(6):2981-2.
1995: Skannal D G; Dungy-Poythress L J; Miodovnik M; First M R
Pregnancy in a combined liver and kidney transplant recipient with type 1 primary hyperoxaluria.
Obstetrics and gynecology 1995;86(4 Pt 2):641-3.
1995: Schroeder T J; Hariharan S; First M R
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations.
Transplantation proceedings 1995;27(1):837-9.
1995: First M R; Combs C A; Weiskittel P; Miodovnik M
Lack of effect of pregnancy on renal allograft survival or function.
Transplantation 1995;59(4):472-6.
1994: Schroeder T J; Hariharan S; First M R
Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipients.
Transplantation proceedings 1994;26(5):2787-90.
1994: Madden R L; Schroeder T J; Alexander J W; First M R
Single dose OKT3: adverse effects, pharmacokinetics, and anti-OKT3 antibody response.
Transplantation science 1994;4(1):111-4.
1994: Schroeder T J; Michael A T; First M R; Hariharan S; Bhat G; Hanto D W; Ryckman F C; Balistreri W F
Variations in serum OKT3 concentration based upon age, sex, transplanted organ, treatment regimen, and anti-OKT3 antibody status.
Therapeutic drug monitoring 1994;16(4):361-7.
1994: First M R; Neylan J F; Rocher L L; Tejani A
Hypertension after renal transplantation.
Journal of the American Society of Nephrology : JASN 1994;4(8 Suppl):S30-6.
1994: Schroeder T J; First M R
Monoclonal antibodies in organ transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1994;23(1):138-47.
1993: Hariharan S; Schroeder T J; Weiskittel P; Alexander J W; First M R
Prednisone withdrawal in HLA identical and one haplotype-matched live-related donor and cadaver renal transplant recipients.
Kidney international. Supplement 1993;43():S30-5.
1993: First M R
Long-term complications after transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(3):477-86.
1993: Rossi S J; Schroeder T J; Hariharan S; First M R
Prevention and management of the adverse effects associated with immunosuppressive therapy.
Drug safety : an international journal of medical toxicology and drug experience 1993;9(2):104-31.
1993: Hariharan S; Schroeder T J; First M R
Effect of race on renal transplant outcome.
Clinical transplantation 1993;7(3):235-9.
1993: Schroeder T J; Sridhar N; Pesce A J; Alexander J W; First M R
Clinical correlations of cyclosporine-specific and -nonspecific assays in stable renal transplants, acute rejection, and cyclosporine nephrotoxicity.
Therapeutic drug monitoring 1993;15(3):190-4.
1993: First M R; Schroeder T J; Michael A; Hariharan S; Weiskittel P; Alexander J W
Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial.
Transplantation 1993;55(5):1000-4.
1993: Schroeder T J; Hariharan S; First M R
Antibody response to OKT3 and methods for monitoring.
Transplantation proceedings 1993;25(2 Suppl 1):77-80.
1993: First M R; Schroeder T J; Hariharan S; Weiskittel P
Reduction of the initial febrile response to OKT3 with indomethacin.
Transplantation proceedings 1993;25(2 Suppl 1):52-4.
1993: First M R; Schroeder T J; Hariharan S
OKT3-induced cytokine-release syndrome: renal effects (cytokine nephropathy).
Transplantation proceedings 1993;25(2 Suppl 1):25-6.
1993: Madden R L; Munda R; Hariharan S; Alexander J W; First M R
Outcome of cadaver kidneys using nonideal donors.
Transplantation proceedings 1993;25(1 Pt 2):1568-9.
1993: First M R; Schroeder T J; Michael A; Hariharan S; Weiskittel P; Alexander J W
Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial.
Transplantation proceedings 1993;25(1 Pt 1):591-4.
1993: Alexander J W; Davies C B; First M R; Cofer B R; Munda R; Madden R L; Hariharan S; Schroeder T J
Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation.
Transplantation proceedings 1993;25(1 Pt 1):485-7.
1993: Schroeder T J; First M R; Pouletty C; Hariharan S; Pouletty P
Rapid detection of anti-OKT3 antibodies with the Transtat assay.
Transplantation 1993;55(2):297-9.
1992: Sridhar N R; Blanton M; Whitacre L; Balakrishnan K; First M R
Flow cytometric evaluation of cytotoxic peripheral blood lymphocytes in acute renal graft rejection.
Journal of the American Society of Nephrology : JASN 1992;3(6):1220-6.
1992: Davies C B; Alexander J W; Cofer B R; First M R; Schroeder T J
Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant.
Annals of surgery 1992;215(6):618-25; discussion 626.
1992: Alexander J W; Babcock G F; First M R; Davies C B; Madden R L; Munda R; Penn I; Fidler J P; Cofer B R; Stephens G
The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial.
Transplantation 1992;53(2):423-7.
1992: First M R; Schroeder T J; Hariharan S; Alexander J W; Weiskittel P
The effect of indomethacin on the febrile response following OKT3 therapy.
Transplantation 1992;53(1):91-4.
1992: Schroeder T J; Helling T; McKenna R M; Rush D; Jeffrey J R; Brewer B; Martin L A; Traylor D; Fisher R A; First M R
A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
Transplantation 1992;53(1):34-40.
1992: First M R
Transplantation in the nineties.
Transplantation 1992;53(1):1-11.
1992: Sridhar N R; Munda R; Balakrishnan K; First M R
Evaluation of flowcytometric crossmatching in renal allograft recipients.
Nephron 1992;62(3):262-6.
1991: Sridhar N R; Tchervenkov J I; Weiss M A; Hijazi Y M; First M R
Disseminated histoplasmosis in a renal transplant patient: a cause of renal failure several years following transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;17(6):719-21.
1991: First M R; Schroeder T J
Solid-organ transplantation in the pediatric population.
Clinical transplantation 1991;5(2 part 2):132-6.
1991: First M R; Schroeder T J; Alexander J W; Stephens G W; Weiskittel P; Myre S A; Pesce A J
Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients.
Transplantation 1991;51(2):365-70.
1991: Fisher R A; Tchervenkov J I; Schroeder T J; Alexander J W; Munda R; Penn I; Carey M; First M R
Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin.
Transplantation proceedings 1991;23(1 Pt 2):1253-5.
1991: Schroeder T J; Weiss M A; Smith R D; Stephens G W; First M R
The efficacy of OKT3 in vascular rejection.
Transplantation 1991;51(2):312-5.
1991: Schroeder T J; Weiss M A; Smith R D; Stephens G W; Carey M; First M R
The use of OKT3 in the treatment of acute vascular rejection.
Transplantation proceedings 1991;23(1 Pt 2):1043-5.
1991: Alexander J W; First M R; Hariharan S; Penn I; Schroeder T; Ryckman F; Munda R; Bhat G; Bolce R
Recent contributions to transplantation at the University of Cincinnati.
Clinical transplants 1991;():159-78.
1991: Myre S A; Schoeder T J; Grund V R; Wandstrat T L; Nicely P G; Pesce A J; First M R
Critical ketoconazole dosage range for ciclosporin clearance inhibition in the dog.
Pharmacology 1991;43(5):233-41.
1990: Tchervenkov J I; Munda R; Weiss M; First M R; Alexander J W
Adult respiratory distress syndrome following chronic rejection of a pancreatic allograft--a case report.
Transplantation 1990;50(5):883-4.
1990: Sridhar N; Schroeder T J; Pesce A J; First M R
Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
Transplantation proceedings 1990;22(3):1257-9.
1990: Pesce A J; Schroeder T J; First M R
An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
Transplantation proceedings 1990;22(3):1171-4.
1990: Schroeder T J; First M R; Mansour M E; Hurtubise P E; Hariharan S; Ryckman F C; Munda R; Melvin D B; Penn I; Ballistreri W F
Antimurine antibody formation following OKT3 therapy.
Transplantation 1990;49(1):48-51.
1990: Schroeder T J; Munda R; Pedersen S H; Hurtubise P E; Alexander J W; First M R
Failure of orthoclone OKT3 retreatment in a pancreas transplant recipient with antimurine antibodies.
Journal of clinical laboratory analysis 1990;4(2):99-101.
1990: First M R
Annual review of transplantation.
Clinical transplants 1990;():357-73.
1989: First M R; Schroeder T J; Carey M A; Chavinson D S
Effect of race on transplant outcome and response to OKT3 monoclonal antibody therapy.
Transplantation proceedings 1989;21(6):3949-52.
1989: First M R; Schroeder T J; Weiskittel P; Myre S A; Alexander J W; Pesce A J
Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients.
Lancet 1989;2(8673):1198-201.
1989: Schroeder T J; First M R; Mansour M E; Alexander J W; Penn I
Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1989;14(5 Suppl 2):14-8.
1989: Schroeder T J; First M R; Hurtubise P E; Marmer D J; Martin D M; Mansour M E; Melvin D B
Immunologic monitoring with Orthoclone OKT3 therapy.
The Journal of heart transplantation 1989;8(5):371-80.
1989: Balakrishnan K; Munda R; First M R; Alexander J W
Outcome of donor specific transfusion renal transplants across B cell positive crossmatches.
Transplantation proceedings 1989;21(1 Pt 2):1836.
1989: Munda R; Hutchins M; First M R; Carey M; Schroeder T; Alexander J W
Infection in OKT3-treated patients receiving additional antirejection therapy.
Transplantation proceedings 1989;21(1 Pt 2):1763-5.
1989: First M R; Schroeder T J; Hurtubise P E; Mansour M E; Penn I; Munda R; Balistreri W F; Alexander J W; Melvin D B; Fidler J P
Immune monitoring during retreatment with OKT3.
Transplantation proceedings 1989;21(1 Pt 2):1753-4.
1989: Hariharan S; First M R; Munda R; Penn I; Schroeder T J; Fidler J; Weiskittel P; Alexander J W
Prednisone withdrawal in HLA-identical living related donor transplant recipients.
Transplantation proceedings 1989;21(1 Pt 2):1617-9.
1989: First M R; Smith R D; Weiss M A; Schroeder T J; Kant K S; Munda R; Stephens G W; Penn I; Alexander J W
Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation.
Transplantation proceedings 1989;21(1 Pt 2):1567-70.
1989: Munda R; First M R; Kranias G; Alexander J W
Effects of pancreatic transplantation on diabetic complications.
Transplantation proceedings 1989;21(1 Pt 3):2865-6.
1989: Myre S A; Schroeder T J; Melvin D B; Pesce A J; Collins J A; Stephens G W; First M R
Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2484-6.
1989: Schroeder T J; Brunson M E; Pesce A J; Hindenlang L L; Mauser P A; Ruckrigl D I; Weibel M L; Wadih G; First M R
A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
Transplantation 1989;47(2):262-6.
1989: Schroeder T J; Myre S A; Melvin D B; Van der Bel-Kahn J; Stephens G W; Collins J A; Wolf R K; Brown L L; Pesce A J; First M R
Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantation.
The Journal of heart transplantation 1989;8(1):5-10.
1989: First M R; Schroeder T J; Hurtubise P E; Mansour M E; Penn I; Munda R; Balistreri W F; Alexander J W; Melvin D B; Fidler J P
Successful retreatment of allograft rejection with OKT3.
Transplantation 1989;47(1):88-91.
1989: Schroeder T J; Pesce A J; Hindenlang L L; Mauser P A; Ruckrigl D L; Weibel M L; Wadih G; First M R
An evaluation of the cyclosporine and metabolites whole blood TDx assay.
Therapeutic drug monitoring 1989;11(4):480-2.
1988: Shah B; First M R; Munda R; Penn I; Fidler J P; Alexander J W
Current experience with renal transplantation in older patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;12(6):516-23.
1988: Clardy C W; Schroeder T J; Myre S A; Wadhwa N K; Pesce A J; First M R; McEnery P T; Balistreri W F; Harris R E; Melvin D B
Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants.
Clinical chemistry 1988;34(10):2012-5.
1988: Munda R; Schroeder T J; Pedersen S A; Clardy C W; Wadhwa N K; Myre S A; Stephens G W; Pesce A J; Alexander J W; First M R
Cyclosporine pharmacokinetics in pancreas transplant recipients.
Transplantation proceedings 1988;20(2 Suppl 2):487-90.
1988: Schroeder T J; Pesce A J; Hassan F M; Wermeling J R; Warner A; Schlueter K T; First M R
Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
Transplantation proceedings 1988;20(2 Suppl 2):345-7.
1988: Shah B; First M R; Mendoza N C; Clyne D H; Alexander J W; Weiss M A
Alport's syndrome: risk of glomerulonephritis induced by anti-glomerular-basement-membrane antibody after renal transplantation.
Nephron 1988;50(1):34-8.
1987: Wadhwa N K; Schroeder T J; Pesce A J; Myre S A; Clardy C W; First M R
Cyclosporine drug interactions: a review.
Therapeutic drug monitoring 1987;9(4):399-406.
1987: Schroeder T J; Melvin D B; Clardy C W; Wadhwa N K; Myre S A; Reising J M; Wolf R K; Collins J A; Pesce A J; First M R
Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients.
The Journal of heart transplantation 1987;6(2):84-9.
1987: Wadhwa N K; Schroeder T J; O'Flaherty E; Pesce A J; Myre S A; First M R
The effect of oral metoclopramide on the absorption of cyclosporine.
Transplantation proceedings 1987;19(1 Pt 2):1730-3.
1987: Wadhwa N K; Schroeder T J; O'Flaherty E; Pesce A J; Myre S A; First M R
The effect of oral metoclopramide on the absorption of cyclosporine.
Transplantation 1987;43(2):211-3.
1987: Munda R; Weiss M A; First M R; Alexander J W
Synchronous pancreatic and renal allografts with urinary tract drainage of the pancreas.
Transplantation proceedings 1987;19(1 Pt 3):2343-4.
1987: Wadhwa N K; Schroeder T J; O'Flaherty E; Pesce A J; Myre S A; Munda R; First M R
Interaction between erythromycin and cyclosporine in a kidney and pancreas allograft recipient.
Therapeutic drug monitoring 1987;9(1):123-5.
1986: First M R; Alexander J W; Wadhwa N; Penn I; Munda R; Fidler J P; Weiskittel P
The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
Transplantation proceedings 1986;18(2 Suppl 1):132-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Roy First

Research Profile (preview)

Procedures

Physiology

Chemicals & Drugs

Concepts & Ideas

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Roy First (preview)

All Publications